Page 39 - U.S. Growth Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Apr 23, 2026

Discover U.S. Growth Stocks that are on the NYSE and NASDAQ. Sorted by forecasted growth, these stocks have higher than expected earnings or sales growth compared to other companies.

5,155 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
KOD	US$45.21	11.9%	979.0%	US$2.8b	US$56.33	17.7	50.5%	n/a	Pharmaceuticals & Biotech
RGNX	US$8.76	-7.7%	-4.3%	US$464.0m	US$27.82	2.7	50.5%	n/a	Pharmaceuticals & Biotech
TVTX	US$40.82	3.2%	131.5%	US$3.7b	US$48.86	7.7	50.4%	n/a	Pharmaceuticals & Biotech
WOOF	US$2.94	-3.0%	-4.9%	US$850.2m	US$3.52	92.2	50.4%	n/a	Retail
CWAN	US$24.15	0.2%	6.2%	US$7.1b	US$24.47	9.7	50.3%	n/a	Software
VRCA	US$6.98	10.4%	42.7%	US$111.5m	US$16.50	3.4	50.3%	n/a	Pharmaceuticals & Biotech
BARK	US$9.57	-5.9%	-60.1%	US$81.7m	US$35.00	1.0	50.2%	n/a	Retail
OTLK	US$0.32	1.9%	-79.4%	US$30.0m	US$4.17	160.3	50.2%	n/a	Pharmaceuticals & Biotech
APLS	US$40.94	0.1%	134.1%	US$5.2b	US$40.93	234.1	50.1%	n/a	Pharmaceuticals & Biotech
DFIN	US$50.49	-3.8%	12.3%	US$1.3b	US$64.33	39.9	50.0%	n/a	Diversified Financials
MNKD	US$2.71	-1.5%	-42.0%	US$846.1m	US$7.17	142.7	50.0%	n/a	Pharmaceuticals & Biotech
HGV	US$46.13	-5.9%	33.9%	US$3.8b	US$55.10	46.4	50.0%	n/a	Consumer Services
NVCT	US$8.90	0%	-15.2%	US$232.9m	US$16.80	12.8	49.9%	n/a	Pharmaceuticals & Biotech
MNPR	US$53.20	-5.4%	24.6%	US$356.3m	US$112.79	2.6	49.9%	n/a	Pharmaceuticals & Biotech
XFOR	US$4.11	-4.2%	-27.9%	US$389.1m	US$11.67	10.6	49.9%	n/a	Pharmaceuticals & Biotech
ZS	US$135.50	0.6%	-37.1%	US$21.4b	US$229.45	7.3	49.8%	n/a	Software
MBRX	US$2.54	5.0%	-90.4%	US$13.6m	US$21.00	0.9	49.8%	n/a	Pharmaceuticals & Biotech
RC	US$1.86	0.5%	-57.9%	US$295.6m	US$1.80	0.2	49.8%	2.2%	Diversified Financials
OPFI	US$8.73	-1.5%	-5.8%	US$729.5m	US$13.33	8.8	49.8%	2.9%	Diversified Financials
SNDK	US$989.90	7.5%	2,913.4%	US$137.6b	US$928.05	16.4	49.7%	n/a	Tech
INMB	US$1.39	-4.1%	-82.2%	US$36.7m	US$7.00	739.1	49.6%	n/a	Pharmaceuticals & Biotech
SINT	US$2.47	-8.2%	-4.3%	US$10.3m	US$10.17	10.0	49.6%	n/a	Healthcare
CTOR	US$0.88	-0.09%	20.3%	US$86.3m	US$6.00	19.6	49.5%	n/a	Pharmaceuticals & Biotech
BILL	US$37.19	-4.2%	-17.8%	US$3.6b	US$55.19	2.4	49.5%	n/a	Software

Page 39 of 215